vs
Side-by-side financial comparison of PTC THERAPEUTICS, INC. (PTCT) and Urban Edge Properties (UE). Click either name above to swap in a different company.
PTC THERAPEUTICS, INC. is the larger business by last-quarter revenue ($164.7M vs $132.6M, roughly 1.2× Urban Edge Properties). Urban Edge Properties runs the higher net margin — 17.1% vs -82.0%, a 99.0% gap on every dollar of revenue. On growth, Urban Edge Properties posted the faster year-over-year revenue change (12.2% vs -22.7%). Over the past eight quarters, Urban Edge Properties's revenue compounded faster (11.6% CAGR vs -11.5%).
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
Urban Edge Properties is a publicly traded real estate investment trust (REIT) that owns, operates, and develops high-quality retail and mixed-use properties, primarily located in densely populated urban and suburban markets across the United States. Its portfolio covers grocery-anchored shopping centers, lifestyle outlets, and community-focused commercial assets.
PTCT vs UE — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $164.7M | $132.6M |
| Net Profit | $-135.0M | $22.6M |
| Gross Margin | — | — |
| Operating Margin | -43.3% | — |
| Net Margin | -82.0% | 17.1% |
| Revenue YoY | -22.7% | 12.2% |
| Net Profit YoY | -104.8% | -6.7% |
| EPS (diluted) | $-1.63 | $0.18 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $132.6M | ||
| Q4 25 | $164.7M | $119.6M | ||
| Q3 25 | $211.0M | $120.1M | ||
| Q2 25 | $178.9M | $114.1M | ||
| Q1 25 | $1.2B | $118.2M | ||
| Q4 24 | $213.2M | $116.4M | ||
| Q3 24 | $196.8M | $112.4M | ||
| Q2 24 | $186.7M | $106.5M |
| Q1 26 | — | $22.6M | ||
| Q4 25 | $-135.0M | $12.4M | ||
| Q3 25 | $15.9M | $14.9M | ||
| Q2 25 | $-64.8M | $58.0M | ||
| Q1 25 | $866.6M | $8.2M | ||
| Q4 24 | $-65.9M | $30.1M | ||
| Q3 24 | $-106.7M | $9.1M | ||
| Q2 24 | $-99.2M | $30.8M |
| Q1 26 | — | — | ||
| Q4 25 | -43.3% | 11.3% | ||
| Q3 25 | 1.4% | 13.4% | ||
| Q2 25 | -19.5% | 53.9% | ||
| Q1 25 | 82.5% | 7.6% | ||
| Q4 24 | -76.2% | 27.6% | ||
| Q3 24 | -27.7% | 8.9% | ||
| Q2 24 | -21.5% | 30.6% |
| Q1 26 | — | 17.1% | ||
| Q4 25 | -82.0% | 10.4% | ||
| Q3 25 | 7.5% | 12.4% | ||
| Q2 25 | -36.3% | 50.8% | ||
| Q1 25 | 73.7% | 6.9% | ||
| Q4 24 | -30.9% | 25.9% | ||
| Q3 24 | -54.2% | 8.1% | ||
| Q2 24 | -53.1% | 28.9% |
| Q1 26 | — | $0.18 | ||
| Q4 25 | $-1.63 | $0.09 | ||
| Q3 25 | $0.20 | $0.12 | ||
| Q2 25 | $-0.83 | $0.46 | ||
| Q1 25 | $10.04 | $0.07 | ||
| Q4 24 | $-0.85 | $0.25 | ||
| Q3 24 | $-1.39 | $0.07 | ||
| Q2 24 | $-1.29 | $0.26 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.9B | $50.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-205.3M | $1.4B |
| Total Assets | $2.9B | $3.4B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $50.0M | ||
| Q4 25 | $1.9B | $48.9M | ||
| Q3 25 | $1.7B | $77.8M | ||
| Q2 25 | $2.0B | $53.0M | ||
| Q1 25 | $2.0B | $48.0M | ||
| Q4 24 | $1.1B | $41.4M | ||
| Q3 24 | $1.0B | $67.9M | ||
| Q2 24 | $1.1B | $78.6M |
| Q1 26 | — | $1.4B | ||
| Q4 25 | $-205.3M | $1.4B | ||
| Q3 25 | $-155.8M | $1.4B | ||
| Q2 25 | $-206.5M | $1.4B | ||
| Q1 25 | $-185.8M | $1.4B | ||
| Q4 24 | $-1.1B | $1.4B | ||
| Q3 24 | $-1.1B | $1.3B | ||
| Q2 24 | $-980.2M | $1.3B |
| Q1 26 | — | $3.4B | ||
| Q4 25 | $2.9B | $3.3B | ||
| Q3 25 | $2.6B | $3.3B | ||
| Q2 25 | $2.6B | $3.3B | ||
| Q1 25 | $2.7B | $3.3B | ||
| Q4 24 | $1.7B | $3.3B | ||
| Q3 24 | $1.8B | $3.2B | ||
| Q2 24 | $1.9B | $3.2B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.3M | $39.1M |
| Free Cash FlowOCF − Capex | $-36.6M | — |
| FCF MarginFCF / Revenue | -22.3% | — |
| Capex IntensityCapex / Revenue | 1.4% | 1.5% |
| Cash ConversionOCF / Net Profit | — | 1.73× |
| TTM Free Cash FlowTrailing 4 quarters | $702.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $39.1M | ||
| Q4 25 | $-34.3M | $182.7M | ||
| Q3 25 | $-66.3M | $55.7M | ||
| Q2 25 | $-58.3M | $43.5M | ||
| Q1 25 | $870.1M | $32.6M | ||
| Q4 24 | $-30.0M | $153.2M | ||
| Q3 24 | $-77.0M | $36.6M | ||
| Q2 24 | $-71.5M | $41.2M |
| Q1 26 | — | — | ||
| Q4 25 | $-36.6M | $81.8M | ||
| Q3 25 | $-69.7M | $26.1M | ||
| Q2 25 | $-59.6M | $19.6M | ||
| Q1 25 | $868.4M | $11.9M | ||
| Q4 24 | $-33.8M | $42.5M | ||
| Q3 24 | $-77.5M | $12.2M | ||
| Q2 24 | $-78.8M | $19.9M |
| Q1 26 | — | — | ||
| Q4 25 | -22.3% | 68.4% | ||
| Q3 25 | -33.1% | 21.7% | ||
| Q2 25 | -33.3% | 17.2% | ||
| Q1 25 | 73.8% | 10.0% | ||
| Q4 24 | -15.8% | 36.6% | ||
| Q3 24 | -39.4% | 10.8% | ||
| Q2 24 | -42.2% | 18.6% |
| Q1 26 | — | 1.5% | ||
| Q4 25 | 1.4% | 84.4% | ||
| Q3 25 | 1.6% | 24.6% | ||
| Q2 25 | 0.7% | 20.9% | ||
| Q1 25 | 0.1% | 17.5% | ||
| Q4 24 | 1.8% | 95.1% | ||
| Q3 24 | 0.3% | 21.7% | ||
| Q2 24 | 4.0% | 20.1% |
| Q1 26 | — | 1.73× | ||
| Q4 25 | — | 14.71× | ||
| Q3 25 | -4.17× | 3.73× | ||
| Q2 25 | — | 0.75× | ||
| Q1 25 | 1.00× | 3.97× | ||
| Q4 24 | — | 5.09× | ||
| Q3 24 | — | 4.03× | ||
| Q2 24 | — | 1.34× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PTCT
Segment breakdown not available.
UE
| Rental revenue | $124.2M | 94% |
| Other | $8.4M | 6% |
